• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗库溴铵诱导全身麻醉下病态肥胖患者肌松作用逆转时,琥珀酸舒更葡糖钠与新斯的明的随机对照比较。

Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.

机构信息

Department of Anaesthesiology and Intensive Therapy, BarlickiUniversity Hospital, Medical University of Lodz, Poland.

出版信息

Br J Anaesth. 2012 Feb;108(2):236-9. doi: 10.1093/bja/aer330. Epub 2011 Oct 19.

DOI:10.1093/bja/aer330
PMID:22012861
Abstract

BACKGROUND

Complete and fast recovery of neuromuscular function is very important in morbidly obese patients because of the possible influence of postoperative residual curarization (PORC) on respiratory function in the postoperative period. Recent reports underline incidences of the residual influence of neuromuscular blocking agents.

METHODS

Seventy morbidly obese (BMI >40 kg m(-2)) patients requiring general anaesthesia and receiving rocuronium for muscle relaxation were randomly assigned into two groups: at the end of the anaesthetic procedure, one group received sugammadex 2 mg kg(-1) of corrected body weight (Group SUG) and the other group received neostigmine 0.05 mg kg(-1) of CBW (Group NEO). At the end of surgery and when response reached a train-of-four (TOF) score of 2, patients received the study drugs. The neuromuscular function was recorded and time to achieve 90% of TOF (safe extubation) was measured. Patients were examined directly after arrival to the post-anaesthesia care unit (PACU) by a blinded investigator for the presence of PORC.

RESULTS

Thirty-five patients received sugammadex and 35 neostigmine. Mean dose of rocuronium was 87.9 vs 85.6 mg (P>0.05), mean time to 90% of TOF was 2.7 vs 9.6 min (P<0.05), and TOF at the PACU was 109.8% vs 85.5% (P<0.05) in Groups SUG and NEO, respectively.

CONCLUSIONS

Administration of sugammadex provides fast recovery of neuromuscular function and prevents PORC in the morbidly obese, however neostigmine does not.

摘要

背景

由于术后残余肌松(PORC)可能对术后呼吸功能产生影响,病态肥胖患者的神经肌肉功能需要完全且快速恢复。最近的报告强调了神经肌肉阻滞剂残留影响的发生率。

方法

70 例病态肥胖(BMI>40kg/m²)患者需全身麻醉并接受罗库溴铵肌松,随机分为两组:麻醉程序结束时,一组给予舒更葡糖钠 2mg/kg 矫正体重(SUG 组),另一组给予新斯的明 0.05mg/kg 矫正体重(NEO 组)。手术结束时,当肌颤搐达到 4 个成串刺激(TOF)的 2 倍时,患者接受研究药物。记录神经肌肉功能,并测量达到 90%TOF(安全拔管)的时间。患者在直接到达麻醉后监护病房(PACU)后由一名盲法研究者检查 PORC 的存在情况。

结果

35 例患者接受舒更葡糖钠,35 例患者接受新斯的明。罗库溴铵的平均剂量分别为 87.9mg 和 85.6mg(P>0.05),达到 90%TOF 的平均时间分别为 2.7min 和 9.6min(P<0.05),TOF 在 PACU 时分别为 109.8%和 85.5%(P<0.05)。

结论

舒更葡糖钠的给药可使病态肥胖患者的神经肌肉功能快速恢复,并预防 PORC,但新斯的明则不能。

相似文献

1
Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.罗库溴铵诱导全身麻醉下病态肥胖患者肌松作用逆转时,琥珀酸舒更葡糖钠与新斯的明的随机对照比较。
Br J Anaesth. 2012 Feb;108(2):236-9. doi: 10.1093/bja/aer330. Epub 2011 Oct 19.
2
Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.与新斯的明用于顺式阿曲库铵诱导的神经肌肉阻滞逆转相比,舒更葡糖用于罗库溴铵诱导的神经肌肉阻滞逆转更快。
Br J Anaesth. 2008 May;100(5):622-30. doi: 10.1093/bja/aen037. Epub 2008 Apr 2.
3
Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.舒更葡糖钠对术后残余肌松发生率的影响:一项随机对照研究。
Br J Anaesth. 2015 Nov;115(5):743-51. doi: 10.1093/bja/aev104. Epub 2015 May 2.
4
Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.舒更葡糖钠逆转罗库溴铵所致深度神经肌肉阻滞的效果:与新斯的明的随机对照比较
Anesthesiology. 2008 Nov;109(5):816-24. doi: 10.1097/ALN.0b013e31818a3fee.
5
A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.舒更葡糖钠与新斯的明用于小儿罗库溴铵诱导的神经肌肉阻滞逆转的比较。
Acta Anaesthesiol Scand. 2017 Apr;61(4):374-380. doi: 10.1111/aas.12868. Epub 2017 Feb 10.
6
Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.在没有监测的情况下使用 sugammadex 逆转未能排除残余神经肌肉阻滞。
Anesth Analg. 2013 Aug;117(2):345-51. doi: 10.1213/ANE.0b013e3182999672. Epub 2013 Jun 11.
7
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.舒更葡糖钠逆转罗库溴铵诱导的神经肌肉阻滞:与新斯的明-格隆溴铵及依酚氯铵-阿托品的比较
Anesth Analg. 2007 Mar;104(3):569-74. doi: 10.1213/01.ane.0000248224.42707.48.
8
Sugammadex allows fast-track bariatric surgery.苏伽达ex 可实现快速通道减重手术。
Obes Surg. 2013 Oct;23(10):1558-63. doi: 10.1007/s11695-013-0926-y.
9
Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.罗库溴铵诱导深度神经肌肉阻滞后使用舒更葡糖钠恢复喉返神经功能
J Clin Anesth. 2016 Sep;33:14-9. doi: 10.1016/j.jclinane.2016.01.015. Epub 2016 Apr 6.
10
Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.新斯的明与琥珀酰明胶逆转患者肌松残余与术后呼吸并发症的前瞻性研究。
Minerva Anestesiol. 2016 Jul;82(7):735-42. Epub 2015 Oct 16.

引用本文的文献

1
Reversing rocuronium-induced neuromuscular block by sugammadex: New safety horizon for Indian population.舒更葡糖钠逆转罗库溴铵诱导的神经肌肉阻滞:为印度人群带来新的安全前景。
Natl J Maxillofac Surg. 2025 Jan-Apr;16(1):77-82. doi: 10.4103/njms.njms_210_23. Epub 2025 Apr 28.
2
[Management of neuromuscular block during general anesthesia : Results of a survey in Germany in 2020 compared to the recommendations of the first European guidelines in 2023].[全身麻醉期间神经肌肉阻滞的管理:2020年德国一项调查结果与2023年欧洲首个指南建议的比较]
Anaesthesiologie. 2025 Apr;74(4):207-217. doi: 10.1007/s00101-025-01511-y. Epub 2025 Mar 5.
3
The Efficacy and Adverse Effects of Sugammadex and Neostigmine in Reversing Neuromuscular Blockade Inpatients with Obesity Undergoing Metabolic and Bariatric Surgery: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
肥胖患者行代谢和减重手术后使用琥珀酰明胶和新斯的明逆转神经肌肉阻滞的疗效和不良反应的系统评价:Meta 分析和试验序贯分析。
Medicina (Kaunas). 2024 Nov 8;60(11):1842. doi: 10.3390/medicina60111842.
4
The Dosage of Muscle Relaxants in Morbidly Obese Patients in Daily Practice - A Narrative Review.日常实践中肥胖患者的肌肉松弛剂剂量——一项叙述性综述
Int J Gen Med. 2024 Sep 14;17:4055-4060. doi: 10.2147/IJGM.S474221. eCollection 2024.
5
Sugammadex vs Neostigmine, a Comparison in Reversing Neuromuscular Blockade: A Narrative Review.舒更葡糖钠与新斯的明在逆转神经肌肉阻滞方面的比较:一项叙述性综述
Cureus. 2024 Jul 29;16(7):e65656. doi: 10.7759/cureus.65656. eCollection 2024 Jul.
6
Impact of Sugammadex Versus Neostigmine Reversal on Postoperative Recovery Time in Patients With Obstructive Sleep Apnea Undergoing Bariatric Surgery: A Double-Blind, Randomized Controlled Trial.舒更葡糖钠与新斯的明用于肥胖症手术患者术后恢复时间的影响:一项双盲、随机对照试验。 该研究比较了舒更葡糖钠和新斯的明在接受减肥手术的阻塞性睡眠呼吸暂停患者中对术后恢复时间的影响,采用双盲、随机对照试验设计。
Anesth Analg. 2025 Mar 1;140(3):568-576. doi: 10.1213/ANE.0000000000007013. Epub 2024 Jun 7.
7
Comparison of Different Weight Scalars to Dose Sugammadex for the Reversal of Neuromuscular Blockade in Morbidly Obese Patients: A Systematic Review.不同体重标量与舒更葡糖钠用于肥胖患者神经肌肉阻滞逆转的剂量比较:一项系统评价
Cureus. 2024 Mar 27;16(3):e57057. doi: 10.7759/cureus.57057. eCollection 2024 Mar.
8
Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review.残余肌松对围手术期医疗专业人员而言仍是安全隐患:一项全面综述。
J Clin Med. 2024 Feb 1;13(3):861. doi: 10.3390/jcm13030861.
9
Emergency use of sugammadex after failure of standard reversal drugs and postoperative pulmonary complications: A retrospective cohort study.标准逆转药物失效后舒更葡糖钠的紧急使用与术后肺部并发症:一项回顾性队列研究
J Anaesthesiol Clin Pharmacol. 2023 Apr-Jun;39(2):232-238. doi: 10.4103/joacp.joacp_289_21. Epub 2023 Mar 1.
10
Superiority of sugammadex in preventing postoperative pulmonary complications.顺式阿曲库铵预注对预防术后肺部并发症的优势。
Chin Med J (Engl). 2023 Jul 5;136(13):1551-1559. doi: 10.1097/CM9.0000000000002381.